摘要
【目的】评价干扰素α-1b合穿琥宁对流行性腮腺炎治疗效果。【方法】随机将90例流行性腮腺炎患者分为治疗组及对照组。治疗组给予穿琥宁10～15 mg/kg加入5%葡萄糖100ml中静滴,1次/d,α-1b干扰素100万IU,肌注,1次/d,连用3 d。对照组：在常规治疗基础上,板兰根冲剂,每次5～10 g,3次/d,给予利巴韦林10～15 mg/kg,静滴,1次/d,疗程5 d。【结果】治疗组在控制发热、消肿、并发症等指标显著优于对照组,在统计学上两组间具有显著性差异。【结论】干扰素α-1b合穿琥宁治疗流行性腮腺炎具有疗效肯定、见效快、副作用少等优点,宜临床推广使用。
[Objective] To study the clinical effect of interferon α-1b combined with chuanhuning in the treatment of epidemic parotitis. [Methods] A total of 90 patients with epidemic parotitis were randomly allocated into two groups. 45 patients in treatment group were given interferon α-1b 100MU, ira, qd × 3 d, and 10 - 15 mg/kg Chuanhuning in 5% 100 ml glucose injection liquid, once a day. And the control group were given libavirin 10 - 15 mg/ （kg. d）^-1 of injection and with Banlangen 5 - 10 g, 3 times a day. The treatment period for both groups was 5 day. [Results] By comparison, the clinical effect of the treatment group was significantly better than the control （P 〈 0.01）. [Conclusions] The clinical effect of interferon α-1b combined with Chuanhuning in treating epidemic parotitis is satisfactory.
出处
《武警医学院学报》
CAS
2008年第1期23-24,共2页
Acta Academiae Medicinae CPAPF
